liver disease
Can Nutritional Wellness Keep Liver Disease at Bay?
Matthew Kappus, MD, an associate professor of medicine and a transplant hepatologist at Duke University, in Durham, ...
AUGUST 29, 2024
FDA Approves Seladelpar for Primary Biliary Cholangitis
The FDA has granted accelerated approval to Livdelzi in combination with ursodeoxycholic acid for adults with PBC.
AUGUST 23, 2024
Survodutide Shows Significant Improvement in MASH and Liver Fibrosis in Phase 2 Trial
Patients taking the glucagon/glucagon-like peptide-1 receptor dual agonist survodutide saw an 83% improvement in ...
AUGUST 9, 2024
Shortened Protocol Can Prevent Infection in Recipients of HCV+ Organs
A shortened antiviral protocol adding ezetimibe can prevent infection in solid-organ recipients who receive ...
AUGUST 6, 2024
Low-Dose Aspirin Reduces Liver Fat in Patients With MASLD in Phase 2 Trial
A daily dose of aspirin led to a significant reduction in liver fat in patients with metabolic ...
AUGUST 2, 2024
Patient-Reported Outcomes Can Help Drive Drug Compliance
Incorporating patient-reported outcome measures such as disease symptoms and quality of life can increase ...
MAY 31, 2024
Identifying and Managing Malnutrition Related to Liver Disease
Liver disease is a common cause of malnutrition in adults and children. Understanding common nutrient deficiencies, ...
APRIL 18, 2023
Seladelpar Improves Transplant-Free Survival at 2 Years
San Diego—If approved, a therapy in development for primary biliary cholangitis might allow some patients ...
OCTOBER 19, 2022
Survey Documents Pandemic’s Toll On Liver Cancer Screening
Clinicians and patients faced significant disruption in liver cancer screening during the early COVID-19 pandemic, ...
NOVEMBER 10, 2021
VA Study Finds Alarming Gaps in Cirrhosis Diagnosis
New research has found that nearly half of patients who receive care at Veterans Health Administration hospitals ...
SEPTEMBER 10, 2021
Undertreated HCV During COVID-19 Seen Increasing Global Liver-Related Deaths
The COVID-19 pandemic’s hindrance of global and regional efforts to eliminate hepatitis C likely will result ...
JULY 14, 2021
Trial Results Mixed for Frontrunning NASH Therapy
For treatment of non-alcoholic steatohepatitis, obeticholic acid met one of its primary end points but not the ...
MARCH 18, 2020
